Evidence of molecular alterations in the tumour suppressor gene WWOX in benign and malignant bone related lesions of the jaws

Oncology Reports

Volumn 25, Issue 2, 2011, Pages 499-502

  Diniz, Marina Gonçalves ^a   Borges, Erica Rievrs ^a   Pimenta, Flavio Juliano ^a   Netto, Ana Carolina De Mesquita ^a   De Marco, Luiz ^a   Gomez, Ricardo Santiago ^a   Gomes, Carolina Cavaliéri ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Benign fibro osseous lesions; Fibrosarcoma; Fibrous dysplasia; Ossifying fibroma; Osteosarcoma; WWOX

Indexed keywords

MESSENGER RNA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FIBROSARCOMA; FIBROUS DYSPLASIA; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; MALE; OSSIFYING FIBROMA; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WWOX GENE;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; FEMALE; FIBROMA, OSSIFYING; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; JAW NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OXIDOREDUCTASES; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 78651373472     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2010.1094     Document Type: Article

References (28)

1. Tang N, Song WX, Luo J, Haydon RC and He TC: Osteosarcoma development and stem cell. Clin Orthop Relat Res 466: 2114-2130, 2008.
2. Folpe AL: Soft-tissue tumours of the head and neck. In: Diagnostic Surgical Pathology of the Head and Neck. Gneep DR (ed). Elsevier, Philadelphia, pp660-663, 2009.
3. Sandberg AA: Cytogenetics and molecular genetics of bone and soft-tissue tumours. Am J Med Genet 115: 189-193, 2002. (Pubitemid 35265509)
4. Speight PM and Carlos R: Maxillofacial fibro-osseous lesions. Cur Diag Pathol 12: 1-10, 2006.
5. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E and Spiegel AM: Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325: 1688-1695, 1991.
6. Schwindinger WF, Francomano CA and Levine MA: Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89: 5152-5156, 1992.
7. Parham DM, Bridge JA, Lukacs JL, Ding Y, Tryka AF and Sawyer JR: Cytogenetic distinction among benign fibro-osseous lesions of bone in children and adolescents: value of karyotypic findings in differential diagnosis. Pediatr Dev Pathol 7: 148-158, 2004. (Pubitemid 38715334)
8. Pimenta FJ, Gontijo Silveira LF, Tavares GC, et al: HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncol 42: 735-739, 2006.
9. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA and Aldaz CM: WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res 60: 2140-2145, 2000. (Pubitemid 30225175)
10. Ried K, Finnis M, Hobson L, et al: Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet 9: 1651-1663, 2000. (Pubitemid 30427002)
11. Del Mare S, Salah Z and Aqeilan RI: WWOX: its genomics, partners, and functions. J Cell Biochem 108: 737-745, 2009.
12. Paige AJ, Taylor KJ, Taylor C, et al: WWOX: a candidate tumour suppressor gene involved in multiple tumour types. Proc Natl Acad Sci USA 98: 11417-11422, 2001. (Pubitemid 32928743)
13. Kuroki T, Trapasso F, Shiraishi T, et al: Genetic alterations of the tumour suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res 62: 2258-2260, 2002. (Pubitemid 34411701)
14. Driouch K, Prydz H, Monese R, Johansen H, Lidereau R and Frengen E: Alternative transcripts of the candidate tumour suppressor gene, WWOX, are expressed at high levels in human breast tumours. Oncogene 21: 1832-1840, 2002.
15. Yendamuri S, Kuroki T, Trapasso F, et al: WW domain containing oxidoredutase gene expression is altered in non-small cell lung cancer. Cancer Res 63: 878-881, 2003. (Pubitemid 36231991)
16. Aqeilan RI, Kuroki T, Pekarsky Y, et al: Loss of WWOX expression in gastric carcinoma. Clin Cancer Res 10: 3053-3058, 2004. (Pubitemid 38619682)
17. Kuroki T, Yendamuri S, Trapasso F, et al: The tumour suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res 10: 2459-2465, 2004. (Pubitemid 38445707)
18. Pimenta FJ, Gomes DA, Perdigao PF, et al: Characterization of the tumour suppressor gene WWOX in primary human oral squamous cell carcinomas. Int J Cancer 118: 1154-1158, 2006.
19. Aqeilan RI, Trapasso F, Hussain S, et al: Targeted deletion of Wwox reveals a tumour suppressor function. Proc Natl Acad Sci USA 104: 3949-3954, 2007. (Pubitemid 47181559)
20. Ludes-Meyers JH, Kil H, Nuñez MI, et al: WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Genes Chromosomes Cancer 46: 1129-1136, 2007. (Pubitemid 47614547)
21. Aqeilan RI, Hassan MQ, de Bruin A, et al: The WWOX tumour suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem 283: 21629-21639, 2008.
22. Ludes-Meyers JH, Kil H, Parker-Thornburg J, et al: Generation and characterization of mice carrying a conditional allele of the Wwox tumour suppressor gene. PLoS ONE 4: e7775, 2009.
23. Yang J, Cogdell D, Yang D, et al: Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma. Cancer Lett 291: 31-38, 2010.
24. Chang NS, Doherty J, Ensign A, Schultz L, Hsu LJ and Hong Q: WOX1 is essential for tumour necrosis factor, UV light, staurosporine, and p53 mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53. Biol Chem 280: 43100-43108, 2005.
25. Aqeilan RI, Pekarsky Y, Herrero JJ, et al: Functional association between Wwox tumour suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci USA 101: 4401-4406, 2004.
26. Gourley C, Paije AJ, Taylor KJ, et al: WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant1 as a tumour suppressor, although the role of variant 4 remains unclear. Int J Oncol 26: 1681-1689, 2005.
27. Aqeilan RI, Hagan JP, Aqeilan HA, Pichiorri F, Fong LY and Croce CM: Inactivation of the Wwox gene accelerates forestomach tumour progression in vivo. Cancer Res 67: 5606-5610, 2007.
28. Kurek KC, Del Mare S, Salah Z, et al: Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. Cancer Res 170: 5577-5586, 2010.